Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Abigail Paras, BS
Advertisement
Articles by Abigail Paras, BS
Advertisement
Latest Updated Articles
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersPublished: August 13th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 2 OPAL Study to Test Muscle-Targeting Therapy Apitegromab in Infants With SMA
2
Interim ROSSINI Data Highlight Foslevodopa/Foscarbidopa’s Impact in Advanced Parkinson Disease
3
Inside the Phase 3 MASCOT Trial: Lundbeck’s Push for the First Disease-Modifying MSA Therapy
4
FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology
5
